According to the Oncology Nursing Society’s new position statement, “Role of the Oncology Nurse Navigator Throughout the Cancer Trajectory,” oncology nurse navigators are crucial to the successful outcomes of patients with cancer. Through clinical expertise, care coordination skills, and leadership abilities, ONNs are able to guide their patients during the cancer trajectory.
In this episode of The Cancer Letter Podcast, Paul Goldberg, editor and publisher of The Cancer Letter, Jacquelyn Cobb, managing editor, discuss the Sept. 23 meeting of the FDA Molecular and Clinical Genetics Panel of the Medical Devices Advisory Committee, during which the panel voted in favor of Galleri, the multi-cancer detection test from GRAIL Inc., to become the first multi-cancer detection test to receive regulatory approval.
